fda approved generic semaglutide Ozempic and Wegovy Don't Exist. The Is Right to Warn Patients FDA approves first-ever oral GLP-1RA

Palatin announces the initiation of a Phase 2 clinical study of Bremelanotide co-administered with a PDE5i for the treatment of erectile dysfunction (ED)

While rare, these can be signs of more serious complications like pancreatitis

Restoring tight junction integrity is thus a promising strategy for protecting the BBB and preventing cognitive dysfunction (Lochhead et al., 2020)

Longevity & Anti-Aging Cellular resilience and healthy-aging objective protocols

Subcutaneous fat shows higher thyroid hormone receptor-1 gene expression than omental fat

Preliminary program results are promising: ~1,500 clients have enrolled in the program since the program launched in April 2023, including: 61% of commercial employer-sponsored lives 17% of commercial health plan lives ** 67% of members meet smart logic criteria and do not require submission of a PA request 84% of PA requests result in denial, and 72% overall target fill rate *** ~$1B or ~$4.86 PMPM in client savings 3 These drugs are being studied in both weight- and non-weight-related conditions